Bulgakov V P, Tchernoded G K, Mischenko N P, Shkryl Yu N, Glazunov V P, Fedoreyev S A, Zhuravlev Yu N
Institute of Biology and Soil Sciences, Far East Branch of the Russian Academy of Sciences, Vladivostok, 690022, Russia.
Biochemistry (Mosc). 2003 Jul;68(7):795-801. doi: 10.1023/a:1025091118544.
It has been reported that rol plant oncogenes located in Ri-plasmids of Agrobacterium rhizogenes activated synthesis of secondary metabolites in the transformed plant cells. The activator mechanism is still unknown. In this work, we studied whether the NADPH oxidase-signaling pathway, which regulates the synthesis of defense metabolites in plants, is involved in the activator function of the rol genes. It was demonstrated that the transformation of Rubia cordifolia cells by the rolB and rolC genes caused an induction of biosynthesis of anthraquinone-type phytoalexins. Inhibition studies revealed a striking difference between the rolC and rolB transformed cultures in their sensitivity to Ca2+ channel blockers and calcium deficiency. The rolC culture displayed lowered resistance to the inhibitors compared to the non-transformed culture, while the rolB culture was more resistant to the treatment. The assumption was made that the oncogenic potential of rol genes is realized through the alteration of calcium balance in the plant cells. Anthraquinone production was not inhibited in the non-transformed and transformed cultures by Ca2+ channel blockers, as well as by diphenylene iodonium, an inhibitor of NADPH oxidase, and by the protein kinase inhibitor staurosporine. These results indicate that the induction of anthraquinone production in transgenic cultures does not involve the activation of Ca2+-dependent NADPH oxidase pathway.
据报道,发根农杆菌Ri质粒中的rol植物致癌基因可激活转化植物细胞中次生代谢产物的合成。其激活机制尚不清楚。在本研究中,我们研究了调节植物防御代谢产物合成的NADPH氧化酶信号通路是否参与rol基因的激活功能。结果表明,rolB和rolC基因对茜草细胞的转化导致了蒽醌型植物抗毒素生物合成的诱导。抑制研究揭示了rolC和rolB转化培养物在对Ca2+通道阻滞剂和钙缺乏的敏感性上存在显著差异。与未转化的培养物相比,rolC培养物对抑制剂的抗性降低,而rolB培养物对处理更具抗性。据此推测,rol基因的致癌潜力是通过改变植物细胞中的钙平衡来实现的。Ca2+通道阻滞剂、NADPH氧化酶抑制剂二亚苯基碘鎓和蛋白激酶抑制剂星形孢菌素在未转化和转化培养物中均未抑制蒽醌的产生。这些结果表明,转基因培养物中蒽醌产生的诱导不涉及Ca2+依赖性NADPH氧化酶途径的激活。